|
| HOW ARTIFICIAL BLOOD WORKS |
|
| HOW ARTIFICIAL BLOOD WORKS |
Unvolunteered Artificial Blood Study WHO: You, the male
and female who is 18 years and older, following trauma have sustained blood loss and are in shock, not have a severe head
injury, be pregnant, in cardiac arrest, or object to participation (if you can verbalize religious objection) or not be wearing
an exclusion bracelet, or be one who has unsurvivable injuries. There is no exclusion for foreign citizens. All people in
the world who are in the specified locations are eligible.
WHAT: Regarding participating in artificial blood study
without consent
Study ID Numbers: RTBSE-11-(N)
ClinicalTrials.gov Identifier: NCT00076648
Health Authority: United
States: Food and Drug Administration (FDA)
WHEN: NOW - Past, Present, and Future
WHERE: United States of America
- please see listing below
WHY: Northfield Laboratories wants to study their product, polyheme.
HOW: Artifical
blood product, polyheme is used as a substitute by medical professionals in emergency vehicles and at various hospitals (see
listing below) for the purpose of studing the effects of their open nonconsented patients.
Citizens who need blood in emergency situations, including becoming severely injured trauma patients from, for instance, automobile
accidents, are likely, without their consent, receive artifical blood. This is not a matter of shortage of blood supply.
The Food and Drug Administration (FDA) approved this experiment for a pharmaceutical company called Northfield Labratories.
The controversial question is whether deaths outweigh the allegations of saving lives due to artificial blood. Obtaining
and wearing a bracelet that says definitively, "I Decline the Northfield Lab PolyhemeŠ Study" will ensure that you
will not be part of the experiment.
About Artificial Blood
More Artificial Blood
Meaning & Other words - "otherwords"
About Artificial Vessels
About "polyheme"
ABC News' "20/20" Investigation - aired Friday, July 7th, 2006:
"Artificial Blood Experiment Hits 27 U.S. Cities"
Artificial Blood Experiment: Is Your City Participating?
Hospitals in Twenty Cities Take Part in Polyheme Trials
By ASA R. ESLOCKER and ASTRID HILL
July 7, 2006 Northfield Lab's experimental blood substitute Polyheme is currently in randomized phase III clinical trials
recruiting patients without informed consent all over the country. At one point, it was being tested in as many as 27 cities;
it is still being tested in 23 hospitals in 20 cities.
With the FDA's approval, Northfield Lab has recruited hospitals to participate in the trial study with exemption from informed
consent requirements on study participants. Although Northfield Lab claims that extensive information on the study has been
made public, a vast majority of the general public has never heard of the trial.
Below is a list of the cities and hospitals that are currently participating in the Polyheme trials. Check the list to see
if you live an area where you could become a trial participant without your informed consent.
To opt out of the study, contact Northfield Labs (http://www.northfieldlabs.com/contact.html) or a participating hospital
and request a blue bracelet. If worn, you will be exempt from the trial.
To Obtain Bracelet contact study centers listed below or directly to:
Northfield Laboratories Inc.
1560 Sherman Avenue
Evanston, Illinois 60201-4800
847-864-3500
California
UC San Diego Medical Center, San Diego, Calif.; No longer recruiting
Scripps Mercy, San Diego, Calif.; No longer recruiting
Colorado
Denver Health Medical Center, Denver, Colo.
Delaware
Christiana Hospital, Newark, Del.
Georgia
Medical Center of Central Georgia, Macon, Ga.
Illinois
Loyola University Medical Center, Maywood, Ill.
Indiana
Wishard Memorial Hospital, Indianapolis, Ind.
Methodist Hospital of Indiana, Indianapolis, Ind.
Kansas
University of Kansas Medical Center, Kansas City, Kan.
Kentucky
University of Kentucky Medical Center, Lexington, Ky.
Michigan
Detroit Receiving Hospital, Detroit, Mich.
Sinai Grace Hospital, Detroit, Mich.
Minnesota
The Mayo Clinic, Rochester, Minn.
New York
Albany Medical Center, Albany, N.Y.; Suspended
North Carolina
Duke University Medical Center, Durham, N.C.
Ohio
MetroHealth Medical Center, Cleveland, Ohio; Suspended
University of Cincinnati Medical Center, Cincinnati, Ohio
Miami Valley Hospital, Dayton, Ohio
Pennsylvania
Lehigh Valley Hospital, Allentown, Penn.; No longer recruiting
St. Luke's Regional Resource Trauma Center, Bethlehem, Penn
Penn State Milton S. Hershey Medical Center, Hershey, Penn.
Tennessee
University of Tennessee-Memphis, Memphis, Tenn.
Johnson City Medical Center, Johnson City, Tenn.; Suspended
Texas
Memorial-Hermann Hospital, Houston, Texas; No longer recruiting
Memorial-Hermann Hospital, Houston, Texas; No longer recruiting
University of Texas Health Science Center, San Antonio, Texas
Brooke Army Medical Center, Fort Sam, Houston, Texas
Utah
University of Utah Health Sciences Center, Salt Lake City, Utah
LDS Hospital, Salt Lake City, Utah
Virginia
Sentara Norfolk Hospital, Norfolk, Va.; No longer recruiting
Virginia Commonwealth University Medical Center, Richmond, Va.
Inova Fairfax Hospital, Falls Church, Va.; Suspended
West Virginia
West Virginia University/Jon Michael Moore Trauma Center, Morgantown, West Va.
(source: www.clinicaltrials.gov where it says "Verified by Northfield Laboratories June 2006)
USA Government Clinical Trials: Study & Updates
|
